15189-14-7

Basic information

• Product Name: Cyclohexanone, 2,2,5,5-tetramethyl-
• CAS NO: 15189-14-7
• Molecular Formula: C10H18O
• Molecular Weight: 154.252
• Mol File: 15189-14-7.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Cyclohexanone, 2,2,5,5-tetramethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanone, 2,2,5,5-tetramethyl-(15189-14-7)
• EPA Substance Registry System: Cyclohexanone, 2,2,5,5-tetramethyl-(15189-14-7)

Safety Data

• Hazardous Substances Data: 15189-14-7(Hazardous Substances Data)

Upstream product

• 37494-08-9 cis-3,3,6,6-Tetramethyl-1,2-cyclohexandiol 
• 129603-27-6 2,2,5,5-tetramethyl-1-(phenylselenomethyl)cyclopentanol 
• 1703-82-8 3-hydroxy-2,2,5,5-tetramethylcyclohexanone 
• 702-50-1 2,2,5,5-tetramethylcyclohexa-1,3-dione 
• 60934-84-1 (1,4,4-trimethylcyclohex-2-en-1-ol) 
• 1073-13-8 4,4-dimethylcyclohexenone 
• 23438-77-9 3,6,6-trimethyl-2-cyclohexen-1-one 
• 917-54-4 methyllithium 
• 33543-18-9 2,5,5-trimethylcyclohexanone 
• 6287-86-1 p-ethoxycarbonylbenzaldehyde 
• 74-88-4 methyl iodide 
• 37490-81-6 (3aS,7aR)-4,4,7,7-Tetramethyl-hexahydro-benzo[1,3,2]dioxathiole 2-oxide 
• 37494-10-3 6-hydroxy-2,2,5,5-tetramethyl-1-cyclohexanone 
• 861538-87-6 2-dichloromethyl-2,5,5-trimethyl-cyclohexanone 

Downstream Products

• 61075-99-8 3,3,6,6-Tetramethyl-1-(3,3,6-trimethyl-hept-1-ynyl)-cyclohexene 
• 37490-75-8 3,3,6,6-Tetramethyl-1-chlorcyclohexen 
• 20651-89-2 3,3,6,6-tetramethylcyclohexane-1,2-dione 
• 1259014-66-8 methyl 3-(1-hydroxy-2,2,5,5-tetramethylcyclohexyl)propiolate 
• 1431464-60-6 6-allyl-2,2,5,5-tetramethylcyclohexanone 
• 1431464-19-5 ethyl 2-(2,2,5,5-tetramethyl-6-oxocyclohexyl)acetate 
• 1259013-87-0 (E)-4-(3-(3,3,6,6-tetramethylcyclohex-1-enyl)acryloyl)piperazine-1-carboxamide 
• 1259013-86-9 (E)-1-morpholino-3-(3,3,6,6-tetramethylcyclohex-1-enyl)prop-2-en-1-one 

Relevant articles and documents

SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS AS RXR AGONISTS

The present invention relates to certain substituted bicyclic compounds that are agonists of RXR and which are therefore useful in the treatment of certain disorders that can be prevented or treated by activation of this receptor. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders.

OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE

Compounds are disclosed that are useful for treating ophthalmic conditions caused by or related to production of toxic visual cycle products that accumulate in the eye, such as dry adult macular degeneration, as well as conditions caused by or related to the misfolding of mutant opsin proteins and/or the mis-localization of opsin proteins. Compositions of these compounds alone or in combination with other therapeutic agents are also described, along with therapeutic methods of using such compounds and/or compositions. Methods of synthesizing such agents are also disclosed.

OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE

Compounds are disclosed that are useful for treating ophthalmic conditions caused by or related to production of toxic visual cycle products that accumulate in the eye, such as dry adult macular degeneration, as well as conditions caused by or related to